A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma Concentration

Clinical trial NCT01403818 · COMPLETED

Trial details

NCT number: NCT01403818
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Pharmacokinetics of ASP1941 Pharmacokinetics of Mitiglinide

Start date: 2011-06-01
Primary completion: 2011-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.